Use of oral midazolam in pediatric upper gastrointestinal endoscopy

Area of Science:

• Pediatric Gastroenterology
• Sedation Pharmacology
• Endoscopic Procedures

Background:

• Sedation is crucial for pediatric upper gastrointestinal (GI) endoscopy.
• Midazolam is commonly used for procedural sedation in children.
• Comparing oral versus intravenous (IV) administration routes is important for optimizing pediatric sedation.

Purpose of the Study:

• To compare the safety and efficacy of oral versus IV midazolam for sedation in pediatric upper GI endoscopy.
• To evaluate key clinical outcomes including vital signs, sedation levels, patient comfort, and recovery.
• To determine the optimal route of midazolam administration for this procedure.

Main Methods:

• Prospective, randomized study involving 61 children under 16 years undergoing upper GI endoscopy.
• Patients were randomized to receive either oral or IV midazolam.
• Comprehensive measurements included vital signs, sedation level, comfort, anxiety, separation ease, procedure duration, and recovery time.

Main Results:

• No significant differences in sedation level, separation ease, monitoring ease, heart rate, blood pressure, or respiratory rate between oral and IV midazolam groups.
• Oxygen saturation was significantly lower in the IV midazolam group at 10 and 30 minutes post-procedure.
• Recovery time was longer in the oral midazolam group compared to the IV group.

Conclusions:

• Oral midazolam is a safe and effective alternative for sedating children undergoing esophagogastroduodenoscopy.
• Oral administration significantly reduces anxiety and enhances overall patient tolerance.
• While IV midazolam may offer faster recovery, oral midazolam presents a viable option with comparable safety in most measured parameters.